ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Iksuda Therapeutics Limited

Iksuda Therapeutics Limited is an active company incorporated on 21 November 2007 with the registered office located in . Iksuda Therapeutics Limited was registered 18 years ago.
Status
Active
Active since incorporation
Company No
06433234
Private limited company
Age
18 years
Incorporated 21 November 2007
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Confirmation
Submitted
Dated 2 November 2025 (1 month ago)
Next confirmation dated 2 November 2026
Due by 16 November 2026 (11 months remaining)
Last change occurred 1 month ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (9 months remaining)
Address
The Biosphere Draymans Way
Newcastle Helix
Newcastle Upon Tyne
NE4 5BX
United Kingdom
Same address for the past 6 years
Telephone
01916031680
Email
Available in Endole App
People
Officers
5
Shareholders
30
Controllers (PSC)
1
Director • American • Lives in United States • Born in Mar 1971
Director • Chief Financial Officer And Director • South Korean • Lives in South Korea • Born in Mar 1962
Director • Chief Executive Officer And Director • South Korean • Lives in South Korea • Born in May 1956
Director • Chief Executive Officer • British • Lives in UK • Born in Dec 1972
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Top Technology Ventures Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Innovations Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Limited
Ip2ipo Services Limited is a mutual person.
Active
Asterion Limited
Ip2ipo Services Limited is a mutual person.
Active
Fusion Ip Sheffield Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Nominees Limited
Ip2ipo Services Limited is a mutual person.
Active
Touchstone Innovations Limited
Ip2ipo Services Limited is a mutual person.
Active
Fusion Ip Cardiff Limited
Ip2ipo Services Limited is a mutual person.
Active
Brands
Iksuda Therapeutics
Iksuda Therapeutics focuses on developing antibody-drug conjugates (ADCs) with enhanced tumor specificity for difficult-to-treat cancers.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£9.29M
Increased by £389K (+4%)
Turnover
Unreported
Same as previous period
Employees
37
Increased by 6 (+19%)
Total Assets
£17.69M
Decreased by £666K (-4%)
Total Liabilities
-£46.26M
Increased by £19.93M (+76%)
Net Assets
-£28.58M
Decreased by £20.6M (+258%)
Debt Ratio (%)
262%
Increased by 118.07% (+82%)
Latest Activity
Confirmation Submitted
1 Month Ago on 13 Nov 2025
Small Accounts Submitted
3 Months Ago on 2 Sep 2025
Seungdeok Jang Resigned
9 Months Ago on 14 Mar 2025
Jeiwook Chae Resigned
9 Months Ago on 14 Mar 2025
Se Jin Park Appointed
9 Months Ago on 14 Mar 2025
Yong Zu Kim Appointed
9 Months Ago on 14 Mar 2025
Confirmation Submitted
1 Year 1 Month Ago on 4 Nov 2024
Dr Jose Ponte Appointed
1 Year 1 Month Ago on 28 Oct 2024
Jinseok Seo Resigned
1 Year 1 Month Ago on 28 Oct 2024
Bong Jin Kwon Resigned
1 Year 1 Month Ago on 28 Oct 2024
Get Credit Report
Discover Iksuda Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 2 November 2025 with updates
Submitted on 13 Nov 2025
Accounts for a small company made up to 31 December 2024
Submitted on 2 Sep 2025
Statement of capital following an allotment of shares on 30 June 2025
Submitted on 23 Jul 2025
Statement of capital following an allotment of shares on 7 April 2025
Submitted on 6 Jun 2025
Change of share class name or designation
Submitted on 16 May 2025
Particulars of variation of rights attached to shares
Submitted on 16 May 2025
Particulars of variation of rights attached to shares
Submitted on 24 Apr 2025
Resolutions
Submitted on 15 Apr 2025
Change of share class name or designation
Submitted on 15 Apr 2025
Termination of appointment of Jeiwook Chae as a director on 14 March 2025
Submitted on 25 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year